Company Overview of Serono Genetics Institute S.A.
Serono Genetics Institute S.A. was acquired by Merck Serono S.A. Serono Genetics Institute S.A. develops and generates drug targets and candidates in the areas of CNS and metabolic disorders. The company was formerly known as Genset S.A. and changed its name to Serono Genetics Institute S.A. in May 2004. Serono Genetics Institute S.A. was incorporated in 1989 and is based in Paris, France.
24, rue Royale
Founded in 1989
33 1 55 04 59 00
33 1 55 04 59 29
Key Executives for Serono Genetics Institute S.A.
Similar Private Companies By Industry
|Acticor Biotech SAS||Europe|
|Aelis Farma S.A.S.||Europe|
|Aenitis Technologies SAS||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Serono Genetics Institute S.A., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.